FIA
NEO icon

FNY Investment Advisers’s NeoGenomics NEO Stock Holding History

FNY Investment Advisers’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-847
Closed -$10K – 868
2018
Q4 		$10K Buy
+847
New +$12.6K ﹤0.01% 438

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FNY Investment Advisers's NEO Position: Q1 2019 in Review

FNY Investment Advisers sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 847 shares — an estimated $10K sold.

FNY Investment Advisers first reported a position in NEO in Q4 2018 and held it in 1 quarter. The position peaked at $10K in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • FNY Investment Advisers reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 847 NeoGenomics shares in Q1 2019, an estimated $10K.
  • FNY Investment Advisers first reported a position in NeoGenomics in Q4 2018 and held it in 1 quarter.
  • FNY Investment Advisers's NeoGenomics position peaked at $10K in Q4 2018.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.